University of Turku celebrates Professor Shimon Sakaguchi’s Nobel prize

Professor Shimon Sakaguchi, winner of the 2025 Nobel Prize in Medicine, is a visiting professor at the IMMUNOCAPs project that profiles research at the University of Turku. The news of Sakaguchi’s award was celebrated at Turku.
Professor Shimon Sakaguchi works at the University of Osaka in Japan.He studies the molecular mechanisms involved in the regulation of the immune system. His research has focused in particular on the development and maintenance of regulatory T cells and their role in immune-mediated diseases.
He is currently investigating how human regulatory T cells can be manipulated to control a variety of physiological and pathological immune responses. For this purpose, Sakaguchi has also set up a company to develop treatments based on regulatory T cells for immune-mediated diseases.
Sakaguchi has close links with the University of Turku, where he last visited in May 2025.
“I am very happy for Professor Sakaguchi. His pioneering work has been insightful, persistent, and has enabled the development of new immunological therapies,” says Professor Riitta Lahesmaa, Director of the IMMUNOCAPs project.
In addition to Sakaguchi, the Nobel Prize in Medicine was awarded to Mary E. Brunkow and Fred Ramsdell from the United States. They have all been studying how to control the harmful cells that cause autoimmune diseases.
“Their discoveries have laid the foundation for a new field of research and spurred the development of new treatments, for example for cancer and autoimmune diseases,” is stated in the award justifications.
The IMMUNOCAPs (Capitalising Immunity to Combat Disease) project led by Lahesmaa focuses on studying the immune system. The aim is to develop new methods to diagnose and treat immune-mediated diseases. IMMUNOCAPs is part of the InFLAMES research flagship and is also part of the University’s health, diagnostics and drug development multidisciplinary research theme.
The winners of the Nobel Prize for Medicine were announced by the Karolinska Institutet on Monday afternoon.
Recent Posts
-
Season’s Greetings & Happy 2026!
Season’s Greetings & Happy 2026! From everyone at Turku Bioscience. Riitta Lahesmaa,Director of Turku Bioscience Read moreDecember 23, 2025
-
The Sigrid Jusélius senior researcher posts grant to Carlos Rogerio Figueiredo
The Sigrid Jusélius Foundation has awarded a four-year senior researcher grant of €700,000 to our Read moreDecember 15, 2025
-
Guillaume Jacquemet awarded the 2025 Chancellor’s Prize
Guillaume Jacquemet, a Group Leader at our centre, has been awarded the Chancellor’s Prize for Read moreDecember 15, 2025
-
New Funding for our Centre’s Researchers
Warm congratulations to all for their funding! Cancer Foundation Finland Project grants Travel grants The Read moreDecember 12, 2025
-
Sami Ventelä and Jukka Westermarck recognized by Medical Association Duodecim for their influential work.
Medical association Duodecim selects each year persons that have been most influential in the field Read moreDecember 11, 2025
-
Our affiliated Group Leader Rafa Najumudeen secures ERC Consolidator Grant
The European Research Council (ERC) has awarded a Consolidator Grant to our affiliated Group Leader, Read moreDecember 9, 2025